论文部分内容阅读
目的:对运用抗血小板聚集方式对患有大面积脑梗死的患者进行治疗的临床效果进行研究分析。方法:抽取72例患有大面积脑梗死患者病例,将其分为A、B2组,平均每组36例。A组患者进行常规治疗;B组患者采用抗血小板聚集方式进行治疗。结果:B组患者在治疗后的病情好转情况明显优于A组患者;在治疗前后的神经功能缺损积分和生活能力评分的改善幅度明显大于A组;治疗过程中出现药物不良反应的人数明显少于A组;实际住院时间明显短于A组。结论:运用抗血小板聚集方式对患有大面积脑梗死的患者进行治疗的临床效果非常明显。
Objective: To study the clinical effect of antiplatelet aggregation on patients with large area cerebral infarction. Methods: Seventy-two patients with large-area cerebral infarction were selected and divided into groups A and B2, with an average of 36 in each group. Patients in group A were treated routinely. Patients in group B were treated with anti-platelet aggregation. Results: Patients in group B improved significantly after treatment than those in group A. The improvement of neurological deficit scores and life ability scores before and after treatment were significantly greater than those in group A. The number of adverse drug reactions in the treatment group was significantly less In group A, the actual hospitalization time was significantly shorter than that in group A. Conclusion: The clinical effect of antiplatelet aggregation on patients with large area cerebral infarction is very obvious.